COLITIS
Clinical trials for COLITIS explained in plain language.
Never miss a new study
Get alerted when new COLITIS trials appear
Sign up with your email to follow new studies for COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody cocktail aims to tame ulcerative colitis for good
Disease control ENROLLING_BY_INVITATIONThis study is testing three long-acting antibodies, alone or in combination, in 645 people with ulcerative colitis. The goal is to see if they are safe and can improve bowel inflammation over 48 weeks. Participants are joining from a previous study and may have already seen some …
Matched conditions: COLITIS
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for immunotherapy side effects: which drug works best for colitis?
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, to treat colitis (colon inflammation) caused by immune checkpoint inhibitor therapy in cancer patients. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer are participating. The goal …
Matched conditions: COLITIS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Texting your doctor: a new way to tame IBD?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether regular text message check-ins and the ability to text your IBD care team can improve disease management and quality of life. About 900 people with Crohn's disease or ulcerative colitis will take part. Some will get extra symptom surveys and texting ac…
Matched conditions: COLITIS
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC